{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:10:57Z","timestamp":1793329857821,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Hebei Province introducing foreign intelligence project in 2020"},{"name":"Hebei Province talent introduction innovation platform in 2021"},{"name":"Hebei Province introducing foreign intelligence project in 2019","award":["2019YX010A"],"award-info":[{"award-number":["2019YX010A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Esketamine, an\n                      <jats:italic>N<\/jats:italic>\n                      -methyl-D-aspartate receptor antagonist, is commonly used for anesthesia and analgesia clinically. It was reported to negatively regulate cell proliferation, metastasis and apoptosis in cancer cells, including lung cancer and pancreatic cancer. However, its impact on esophageal squamous cell carcinoma (ESCC) malignance and underlying mechanism remain elusive. This study was aimed to investigate the antitumor effects of esketamine on ESCC in vitro.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>ESCC cell lines (KYSE-30 and KYSE-150) were cultured and treated with different concentrations (0.1, 0.2, 0.4, 0.8, 1, 2\u00a0mM) of esketamine. Their proliferation, apoptosis, migration and invasion were assessed with various assays. Furthermore, mass spectrometry-based proteomic analysis and GO\/KEGG enrichment analysis were applied to characterize the differentially expressed proteins (DEPs) with or without esketamine treatment. Some key proteins identified from proteomic analysis were further validated with Western blotting and bioinformatics analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Esketamine significantly inhibited the proliferation, migration, invasion and promoted apoptosis of the both types of cell lines in a dose- and time-dependent manner. A total of 321 common DEPs, including 97 upregulated and 224 downregulated proteins, were found with HPLC\u2013MS analyses. GO\/KEGG enrichment analysis suggested that esketamine affected cell population proliferation, GTPase activity and Apelin signaling pathway. The ERCC6L, AHR and KIF2C protein expression was significantly downregulated in these ESCC cells treated with esketamine compared to the controls and their changes were associated with the suppressive effects of esketamine on ESCC through bioinformatics analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our work demonstrated that esketamine has potential anti-ESCC properties in vitro but subjected to further in vivo and clinical study.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40001-023-01511-x","type":"journal-article","created":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T02:02:02Z","timestamp":1700013722000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Potential \u2018anti-cancer\u2019 effects of esketamine on proliferation, apoptosis, migration and invasion in esophageal squamous carcinoma cells"],"prefix":"10.1186","volume":"28","author":[{"given":"Chao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingpu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqun","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,15]]},"reference":[{"key":"1511_CR1","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1053\/j.gastro.2022.05.054","volume":"163","author":"E Morgan","year":"2022","unstructured":"Morgan E, Soerjomataram I, Rumgay H, Coleman HG, Thrift AP, Vignat J, Laversanne M, Ferlay J, Arnold M. The global landscape of esophageal squamous cell carcinoma and esophageal adenocarcinoma incidence and mortality in 2020 and projections to 2040: new estimates from GLOBOCAN 2020. Gastroenterology. 2022;163:649-658.e642.","journal-title":"Gastroenterology"},{"key":"1511_CR2","doi-asserted-by":"publisher","first-page":"535","DOI":"10.21147\/j.issn.1000-9604.2021.05.01","volume":"33","author":"J Li","year":"2021","unstructured":"Li J, Xu J, Zheng Y, Gao Y, He S, Li H, Zou K, Li N, Tian J, Chen W, He J. Esophageal cancer: epidemiology, risk factors and screening. Chin J Cancer Res. 2021;33:535\u201347.","journal-title":"Chin J Cancer Res"},{"key":"1511_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.802210","volume":"12","author":"BS Buddeberg","year":"2022","unstructured":"Buddeberg BS, Seeberger MD. Anesthesia and oncology: friend or foe? Front Oncol. 2022;12: 802210.","journal-title":"Front Oncol"},{"key":"1511_CR4","doi-asserted-by":"publisher","first-page":"191","DOI":"10.4097\/kja.20679","volume":"74","author":"A Alam","year":"2021","unstructured":"Alam A, Rampes S, Patel S, Hana Z, Ma D. Anesthetics or anesthetic techniques and cancer surgical outcomes: a possible link. Korean J Anesthesiol. 2021;74:191\u2013203.","journal-title":"Korean J Anesthesiol"},{"key":"1511_CR5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12871-021-01294-w","volume":"21","author":"M Ishikawa","year":"2021","unstructured":"Ishikawa M, Iwasaki M, Sakamoto A, Ma D. Anesthetics may modulate cancer surgical outcome: a possible role of miRNAs regulation. BMC Anesthesiol. 2021;21:71.","journal-title":"BMC Anesthesiol"},{"key":"1511_CR6","doi-asserted-by":"publisher","DOI":"10.3724\/abbs.2022114","author":"L Gao","year":"2022","unstructured":"Gao L, Yang L, He Y, Liu Y, Xu P, Zhang J, Dai S, Luo X, Sun Z. MOR promotes epithelial-mesenchymal transition and proliferation via PI3K\/AKT signaling pathway in human colorectal cancer. Acta Biochim Biophys Sin (Shanghai). 2022. https:\/\/doi.org\/10.3724\/abbs.2022114.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"1511_CR7","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.3390\/cancers14092253","volume":"14","author":"A Santoni","year":"2022","unstructured":"Santoni A, Santoni M, Arcuri E. Chronic cancer pain: opioids within tumor microenvironment affect neuroinflammation, tumor and pain evolution. Cancers (Basel). 2022;14:2253.","journal-title":"Cancers (Basel)"},{"key":"1511_CR8","doi-asserted-by":"publisher","first-page":"4445","DOI":"10.1002\/jcp.30161","volume":"236","author":"H Lu","year":"2021","unstructured":"Lu H, Zhang H, Weng ML, Zhang J, Jiang N, Cata JP, Ma D, Chen WK, Miao CH. Morphine promotes tumorigenesis and cetuximab resistance via EGFR signaling activation in human colorectal cancer. J Cell Physiol. 2021;236:4445\u201354.","journal-title":"J Cell Physiol"},{"key":"1511_CR9","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1097\/ACO.0000000000000916","volume":"33","author":"W Barrett","year":"2020","unstructured":"Barrett W, Buxhoeveden M, Dhillon S. Ketamine: a versatile tool for anesthesia and analgesia. Curr Opin Anaesthesiol. 2020;33:633\u20138.","journal-title":"Curr Opin Anaesthesiol"},{"key":"1511_CR10","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/cns.12111","volume":"19","author":"J Persson","year":"2013","unstructured":"Persson J. Ketamine in pain management. CNS Neurosci Ther. 2013;19:396\u2013402.","journal-title":"CNS Neurosci Ther"},{"key":"1511_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.599721","volume":"11","author":"C Culp","year":"2020","unstructured":"Culp C, Kim HK, Abdi S. Ketamine use for cancer and chronic pain management. Front Pharmacol. 2020;11: 599721.","journal-title":"Front Pharmacol"},{"key":"1511_CR12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/ijnp\/pyaa068","volume":"24","author":"DF Ionescu","year":"2021","unstructured":"Ionescu DF, Fu DJ, Qiu X, Lane R, Lim P, Kasper S, Hough D, Drevets WC, Manji H, Canuso CM. Esketamine nasal spray for rapid reduction of depressive symptoms in patients with major depressive disorder who have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II). Int J Neuropsychopharmacol. 2021;24:22\u201331.","journal-title":"Int J Neuropsychopharmacol"},{"key":"1511_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2022.109171","volume":"216","author":"K Hirota","year":"2022","unstructured":"Hirota K, Lambert DG. Ketamine; history and role in anesthetic pharmacology. Neuropharmacology. 2022;216: 109171.","journal-title":"Neuropharmacology"},{"key":"1511_CR14","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.yexmp.2019.02.004","volume":"107","author":"W Duan","year":"2019","unstructured":"Duan W, Hu J, Liu Y. Ketamine inhibits colorectal cancer cells malignant potential via blockage of NMDA receptor. Exp Mol Pathol. 2019;107:171\u20138.","journal-title":"Exp Mol Pathol"},{"key":"1511_CR15","doi-asserted-by":"publisher","first-page":"6749","DOI":"10.1007\/s11033-020-05733-8","volume":"47","author":"S Du","year":"2020","unstructured":"Du S, Sung YS, Wey M, Wang Y, Alatrash N, Berthod A, MacDonnell FM, Armstrong DW. Roles of N-methyl-d-aspartate receptors and d-amino acids in cancer cell viability. Mol Biol Rep. 2020;47:6749\u201358.","journal-title":"Mol Biol Rep"},{"key":"1511_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175580","volume":"945","author":"J Saito","year":"2023","unstructured":"Saito J, Zao H, Wu L, Iwasaki M, Sun Q, Hu C, Ishikawa M, Hirota K, Ma D. \u201cAnti-cancer\u201d effect of ketamine in comparison with MK801 on neuroglioma and lung cancer cells. Eur J Pharmacol. 2023;945: 175580.","journal-title":"Eur J Pharmacol"},{"key":"1511_CR17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12871-015-0076-y","volume":"15","author":"M Malsy","year":"2015","unstructured":"Malsy M, Gebhardt K, Gruber M, Wiese C, Graf B, Bundscherer A. Effects of ketamine, s-ketamine, and MK 801 on proliferation, apoptosis, and necrosis in pancreatic cancer cells. BMC Anesthesiol. 2015;15:111.","journal-title":"BMC Anesthesiol"},{"key":"1511_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.597467","volume":"11","author":"T Li","year":"2020","unstructured":"Li T, Yang J, Yang B, Zhao G, Lin H, Liu Q, Wang L, Wan Y, Jiang H. Ketamine inhibits ovarian cancer cell growth by regulating the lncRNA-PVT1\/EZH2\/p57 axis. Front Genet. 2020;11: 597467.","journal-title":"Front Genet"},{"key":"1511_CR19","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12943-022-01686-7","volume":"21","author":"L Gu","year":"2022","unstructured":"Gu L, Sang Y, Nan X, Zheng Y, Liu F, Meng L, Sang M, Shan B. circCYP24A1 facilitates esophageal squamous cell carcinoma progression through binding PKM2 to regulate NF-\u03baB-induced CCL5 secretion. Mol Cancer. 2022;21:217.","journal-title":"Mol Cancer"},{"key":"1511_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.806954","volume":"12","author":"J Shen","year":"2021","unstructured":"Shen J, Han L, Xue Y, Li C, Jia H, Zhu K. Ropivacaine inhibits lung cancer cell malignancy through downregulation of cellular signaling including HIF-1\u03b1 in vitro. Front Pharmacol. 2021;12: 806954.","journal-title":"Front Pharmacol"},{"key":"1511_CR21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.bbrc.2021.11.029","volume":"585","author":"H Li","year":"2021","unstructured":"Li H, Liu W, Zhang X, Wu F, Sun D, Wang Z. Ketamine suppresses proliferation and induces ferroptosis and apoptosis of breast cancer cells by targeting KAT5\/GPX4 axis. Biochem Biophys Res Commun. 2021;585:111\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"1511_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.753598","volume":"11","author":"Y Cheng","year":"2021","unstructured":"Cheng Y, Wang G, Zhao L, Dai S, Han J, Hu X, Zhou C, Wang F, Ma H, Li B, Meng Z. Periplocymarin induced colorectal cancer cells apoptosis via impairing PI3K\/AKT pathway. Front Oncol. 2021;11: 753598.","journal-title":"Front Oncol"},{"key":"1511_CR23","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45:W98-w102.","journal-title":"Nucleic Acids Res"},{"key":"1511_CR24","doi-asserted-by":"publisher","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","volume":"49","author":"D Szklarczyk","year":"2021","unstructured":"Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S, Doncheva NT, Legeay M, Fang T, Bork P, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Res. 2021;49:D605-d612.","journal-title":"Nucleic Acids Res"},{"key":"1511_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7.","journal-title":"BMC Bioinformatics"},{"key":"1511_CR26","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","volume":"39","author":"G Bindea","year":"2013","unstructured":"Bindea G, Mlecnik B, Tosolini M, Kirilovsky A, Waldner M, Obenauf AC, Angell H, Fredriksen T, Lafontaine L, Berger A, et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity. 2013;39:782\u201395.","journal-title":"Immunity"},{"key":"1511_CR27","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1186\/s12885-020-07367-2","volume":"20","author":"H Chen","year":"2020","unstructured":"Chen H, Wang H, Yu X, Zhou S, Zhang Y, Wang Z, Huang S, Wang Z. ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K\/AKT and NF-\u03baB signaling pathway. BMC Cancer. 2020;20:853.","journal-title":"BMC Cancer"},{"key":"1511_CR28","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s12885-023-10788-4","volume":"23","author":"S Liu","year":"2023","unstructured":"Liu S, Ye Z, Xue VW, Sun Q, Li H, Lu D. KIF2C is a prognostic biomarker associated with immune cell infiltration in breast cancer. BMC Cancer. 2023;23:307.","journal-title":"BMC Cancer"},{"key":"1511_CR29","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1007\/s13238-020-00766-y","volume":"12","author":"S Wei","year":"2021","unstructured":"Wei S, Dai M, Zhang C, Teng K, Wang F, Li H, Sun W, Feng Z, Kang T, Guan X, et al. KIF2C: a novel link between Wnt\/\u03b2-catenin and mTORC1 signaling in the pathogenesis of hepatocellular carcinoma. Protein Cell. 2021;12:788\u2013809.","journal-title":"Protein Cell"},{"key":"1511_CR30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.coi.2020.12.003","volume":"70","author":"D Leclerc","year":"2021","unstructured":"Leclerc D, Staats Pires AC, Guillemin GJ, Gilot D. Detrimental activation of AhR pathway in cancer: an overview of therapeutic strategies. Curr Opin Immunol. 2021;70:15\u201326.","journal-title":"Curr Opin Immunol"},{"key":"1511_CR31","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1158\/0008-5472.CAN-21-3868","volume":"82","author":"B Zhang","year":"2022","unstructured":"Zhang B, Peng H, Zhou M, Bao L, Wang C, Cai F, Zhang H, Wang JE, Niu Y, Chen Y, et al. Targeting BCAT1 combined with \u03b1-Ketoglutarate triggers metabolic synthetic lethality in glioblastoma. Cancer Res. 2022;82:2388\u2013402.","journal-title":"Cancer Res"},{"key":"1511_CR32","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41419-022-05140-w","volume":"13","author":"R Liu","year":"2022","unstructured":"Liu R, Liu R, Guo Z, Ren J, Huang J, Luo Q, Tan Q. shRNA-mediated knockdown of KNTC1 inhibits non-small-cell lung cancer through regulating PSMB8. Cell Death Dis. 2022;13:685.","journal-title":"Cell Death Dis"},{"key":"1511_CR33","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1177\/2045125316631267","volume":"6","author":"J Muller","year":"2016","unstructured":"Muller J, Pentyala S, Dilger J, Pentyala S. Ketamine enantiomers in the rapid and sustained antidepressant effects. Ther Adv Psychopharmacol. 2016;6:185\u201392.","journal-title":"Ther Adv Psychopharmacol"},{"key":"1511_CR34","doi-asserted-by":"publisher","first-page":"42","DOI":"10.12688\/f1000research.27809.1","volume":"10","author":"M Fernandes","year":"2021","unstructured":"Fernandes M, Schelotto M, Doldi PM, Milani G, Ariza Manzano AA, Perera Valdivia D, Winter Matos AM, Hamdy Abdelrahim Y, Hamad Bek SA, Benitez BK, et al. IMPORTANCE trial: a provisional study-design of a single-center, phase II, double-blinded, placebo-controlled, randomized, 4-week study to compare the efficacy and safety of intranasal esketamine in chronic opioid refractory pain. F1000Res. 2021;10:42.","journal-title":"F1000Res"},{"key":"1511_CR35","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1001\/jamapsychiatry.2017.3739","volume":"75","author":"EJ Daly","year":"2018","unstructured":"Daly EJ, Singh JB, Fedgchin M, Cooper K, Lim P, Shelton RC, Thase ME, Winokur A, Van Nueten L, Manji H, Drevets WC. Efficacy and safety of intranasal esketamine adjunctive to oral antidepressant therapy in treatment-resistant depression: a randomized clinical trial. JAMA Psychiat. 2018;75:139\u201348.","journal-title":"JAMA Psychiat"},{"key":"1511_CR36","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1038\/s41467-023-37440-w","volume":"14","author":"L Li","year":"2023","unstructured":"Li L, Jiang D, Zhang Q, Liu H, Xu F, Guo C, Qin Z, Wang H, Feng J, Liu Y, et al. Integrative proteogenomic characterization of early esophageal cancer. Nat Commun. 2023;14:1666.","journal-title":"Nat Commun"},{"key":"1511_CR37","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.4081\/ejh.2022.3336","volume":"66","author":"Y Wang","year":"2022","unstructured":"Wang Y, Wang G, Liu X, Yun D, Cui Q, Wu X, Lu W, Yang X, Zhang M. Inhibition of APLN suppresses cell proliferation and migration and promotes cell apoptosis in esophageal cancer cells in vitro, through activating PI3K\/mTOR signaling pathway. Eur J Histochem. 2022;66:3336.","journal-title":"Eur J Histochem"},{"key":"1511_CR38","doi-asserted-by":"publisher","first-page":"4055","DOI":"10.3390\/cells11244055","volume":"11","author":"Y Teng","year":"2022","unstructured":"Teng Y. GTPase pathways in health and diseases. Cells. 2022;11:4055.","journal-title":"Cells"},{"key":"1511_CR39","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s12032-022-01654-7","volume":"39","author":"G Hou","year":"2022","unstructured":"Hou G, Lu Z, Bi Y, Deng J, Yang X. ERCC6L is a biomarker and therapeutic target for non-small cell lung adenocarcinoma. Med Oncol. 2022;39:51.","journal-title":"Med Oncol"},{"key":"1511_CR40","doi-asserted-by":"publisher","first-page":"5673","DOI":"10.3390\/cancers13225673","volume":"13","author":"HH Moon","year":"2021","unstructured":"Moon HH, Kreis NN, Friemel A, Roth S, Schulte D, Solbach C, Louwen F, Yuan J, Ritter A. Mitotic centromere-associated kinesin (MCAK\/KIF2C) regulates cell migration and invasion by modulating microtubule dynamics and focal adhesion turnover. Cancers (Basel). 2021;13:5673.","journal-title":"Cancers (Basel)"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01511-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-023-01511-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01511-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T02:09:02Z","timestamp":1700014142000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-023-01511-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,15]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1511"],"URL":"https:\/\/doi.org\/10.1186\/s40001-023-01511-x","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,15]]},"assertion":[{"value":"28 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors have no ethical, legal and financial conflicts related to the article. All authors read and approved the manuscript to publish.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"517"}}